301
Participants
Start Date
February 28, 2001
Primary Completion Date
February 28, 2003
Study Completion Date
February 28, 2003
mesalamine
mesalamine 2.4 g/day (400 mg tablet) for 6 weeks
mesalamine
mesalamine 4.8 g/day (800 mg tablet) for 6 weeks
Research Site, Birmingham
Research Site, Anaheim
Research Site, Sacramento
Research Site, San Francisco
Research Site, Denver
Research Facility, Golden
Research Site, Bridgeport
Research Site, Fort Myers
Research Site, Hollywood
Research Site, Jupiter
Research Site, Miami
Research Facility, Atlanta
Research Facility, Decatur
Research Site, Arlington Heights
Research Site, Moline
Research Site, Rockford
Research Site, Wichita
Research Site, Metairie
Research Site, Baltimore
Research Site, Laurel
Research Site, Detroit
Research Site, New Brunswick
Research Site, Somerville
Research Site, Great Neck
Research Site, Pomona
Research Facility, Poughkeepsie
Research Site, Raleigh
Research Site, Winston-Salem
Research Site, Cincinnati
Research Site, Tulsa
Research Site, Philadelphia
Research Site, Pittsburgh
Research Site, Charleston
Research Facility, Memphis
Research Facility, Nashville
Research Site, Fort Worth
Research Site, Houston
Research Site, San Antonio
Research Site, Burlington
Research Site, Charlottesville
Research Facility, Falls Church
Research Site, Norfolk
Research Site, Tacoma
Research Site, Milwaukee
Lead Sponsor
Warner Chilcott
INDUSTRY